These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Role of positron emission tomography/computed tomography in breast cancer.
    Author: Bourgeois AC, Warren LA, Chang TT, Embry S, Hudson K, Bradley YC.
    Journal: Radiol Clin North Am; 2013 Sep; 51(5):781-98. PubMed ID: 24010906.
    Abstract:
    Although positron emission tomography (PET) imaging may not be used in the diagnosis of breast cancer, the use of PET/computed tomography is imperative in all aspects of breast cancer staging, treatment, and follow-up. PET will continue to be relevant in personalized medicine because accurate tumor status will be even more critical during and after the transition from a generic metabolic agent to receptor imaging. Positron emission mammography is an imaging proposition that may have benefits in lower doses, but its use is limited without new radiopharmaceuticals.
    [Abstract] [Full Text] [Related] [New Search]